Angiogenesis is essential for development, tissue repair, and vascular homeostasis, whereas dysregulated neovascularization contributes to chronic inflammation, ischemic injury, and cancer progression. Viral infections can reshape vascular programs through endothelial signaling, immune responses, metabolic stress, and...
Qamar Abuhassan, Waleed K. Abdulsahib, Sanan Thaer Abdalwahab et al.· Cancer Treatment and Researc...· 0 citations
INTRODUCTION
Orthopedics could greatly benefit from nanotechnology, especially in drug delivery, bone tissue engineering, and implant design. Nanotheranostics represents a major step toward individualized treatment by combining diagnosis and treatment into a single nanoplatform. For orthopedic applications, nanocarrier...
Qamar Abuhassan, Husni Farah, M. Rekha et al.· Expert Review of Molecular D...· 0 citations
The biological roles, biomarker potential, therapeutic applications, and methodological challenges of EVs in AML are summarized and the priorities required for their future clinical development are highlighted.
G. Oriquat, Shaker Al-Hasnaawei, Hayjaa Mohaisen Mousa et al.· European Journal of Haematol...· 0 citations
Evidence from published clinical studies and 65 registered clinical trials on mRNA-based cancer vaccines are synthesized, summarizing key molecular principles, delivery strategies, clinical translation in solid tumors, and ongoing opportunities for future therapeutic development are summarized.
Zahraa A. Alkhafaje, M. H., Aniruddh Dash et al.· Current Research in Translat...· 0 citations
Overall, EV-ncRNAs represent promising mechanistic biomarkers and therapeutic targets, but rigorous source-specific validation and standardized analytical workflows are required before clinical implementation.
T. AlRamadneh, Waleed K. Abdulsahib, Sanan Thaer Abdalwahab et al.· Cancer Treatment and Researc...· 0 citations
Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.
S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al.· Cell Biology International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
